1Heaney RP.Is the paradigm shifting[J].Bone,2003,33:457.
2Garnero P,Sornay-Rendu E,Claustrar B,et al.Biochemical markers of bone turnover endogenous and the risk of fracture in postmenpausal women:the OFELY study[J].J Bone Miner Res,2000,15:1526.
3Ross PD,Kress BC,Parson RE,et al.Serum bone alkaline phosphatase and calcaneus bone density predict fractures:a prospective study[J].Osteoporos Int,2000,11:76.
3NIH Consensus Development Panel on Osteoporosis Prevention.Diagnosis and Therapy.JAMA,2001,285:785-795.
4Heaney RP.Is the paradigm shifting.Bone,2003,33:457-465.
5Garnero P,Sornay-Rendu E,Claustrar B,et al.Biochemical markets of bone turnover.endogenous hormones and the risk of fracture in postmenpausal women:the OFELY study.J Bone Minter Res,2000,15:1526-1536.
6Ross PD,Kress BC,Parson RE,et al.Serum bone alkaline phosphatase and calcaneus bone density predict fractures:a prospective study.Ostteoporos Int,2000,11:76-82.
7肖间德.实用骨质疏松学.北京:科学出版社,2004:156-157.
8Obrant KJ,Ivaska KK.Gerdhem P,et al.Biochemical markers of bone turnover are influenced by recently sustained fracture.Bone,2005,35:786-792.
9Gomesz B,Ardakani S,Ju J,et al.Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum.ClinChem,1995,1:1560.
10Rifas L,Fausto A,Scott MJ,et al.Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells:differentiation is associated with repression of metalloproteinase biosynthesis.Endocrinology,1994,134:213-221.
7Solomon DH,Finkelstein JS,Shadick N,et al.The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis.Arthritis Rheum,2009,60:1624-1631.
8Chopin F,Garnero P,Henanff A,et al.Long term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.Ann Rheum Dis,2008,67:353-357.
9Cox G,Einhorn TA,Tzioupis C,et al.Bone-turnover markers in fracture healing.J Bone Joint Surg Br,2010,92:329-334.
